Hydrogenation of adipic acid (AA) is a potential way to prepare 1,6‐hexanediol (HDOL). Herein, silica‐supported copper catalysts derived from copper phyllosilicates were synthesized, characterized, and tested in the hydrogenation of AA to HDOL. In a full conversion of AA, a high yield of HDOL (approximately 90 %) was obtained through the use of each Cu‐based catalyst. The turnover frequency calculated according to the consumption rate of AA was discovered to be dependent on the Cu+/(Cu0+Cu+) ratio and the reduction condition. Moreover, recycling tests showed that a catalyst derived from a copper phyllosilicate had better stability compared with Cu/SiO2 made through impregnation due to a stronger interaction between Cu and silica. The kinetic analyses based on the global rate expression and Langmuir−Hinshelwood−Hougen−Watson (LHHW) formalism of AA conversion were conducted. The possible competitive adsorption between AA and its derivatives, including hydroxycaproic acid and ϵ‐caprolactone, was thereby revealed.
NiO
x
-promoted Cu-based catalysts derived
from CuNi phyllosilicates were synthesized, characterized, and tested
in the selective hydrogenation of adipic acid to 1,6-hexanediol. The
reduction of the CuNi phyllosilicate allows finely dispersed Cu0 and Cu+ on the surface. The reduced Cu36Ni5PS catalyst was found to have a higher turnover frequency
for the selective hydrogenation of adipic acid than the reduced Cu41PS, Cu40Ni1PS, and Cu31Ni10PS catalysts. This catalyst is also effective at hydrogenation
of succinic acid, glutaric acid, butyric acid, pentanoic acid, and
hexanoic acid to their respective alcohols. The higher activity of
the reduced Cu36Ni5PS catalyst is attributed
to a higher oxidation state of Cu cations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.